LENSAR opened higher at $4.59, compared with its previous close of $4.58. In the last trading session, the stock traded between $4.41 and $4.87. It showed an upward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in LENSAR is now worth
$ 65.14
Resulting in a loss of
$ 34.86 (34.86%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
+$0.17 (+3.76%)
Day High
$4.87
Day Low
$4.41
Day Open
$4.59
Prev Close
$4.58
Volume
1,13,228
1W Return
-19.99%
1M Return
-24.15%
3M Return
-21.38%
6M Return
-17.79%
1Y Return
-54.53%
Fundamentals
Market Cap ($ Mn)
58
PE Ratio
46.06
PB Ratio
6.83
PEG Ratio
-
ROE
-
ROCE
-84.54%
EPS (TTM)
$0.14
Investment Returns
1 Week
-19.99%
1 Month
-24.15%
3 Months
-21.38%
6 Months
-17.79%
9 Months
-61.74%
Financials
Quarterly
All values in $ Mn
14.2
Mar 25
13.9
Jun 25
14.3
Sep 25
16.0
Dec 25
13.4
Mar 26
16.5
Jun 26
Updates
10Nov
Lensar Q3FY26 Results: Recurring revenue up 17%, operating loss narrows
Total revenue declined 1% YoY to $14.1 million due to lower system sales. Recurring revenue rose 17% YoY to $12.6 million, now 89% of total revenue. Operating loss narrowed to $1.4 million from $7.6 million in Q3FY25. Procedure volume increased 12% YoY to 52,545 procedures. Global ALLY installed base grew to approximately 225 systems.
2 days ago
13Aug
Lensar Q2 EPS $0.10 beats estimate; sales up 18% to $16.5M
Lensar reported Q2 2026 EPS of $0.10, beating estimates of $(0.17), with revenue rising 18% to $16.5M. Procedure volume grew 13% to 58,682, driving recurring revenue to 83% of total top line. Gross margin expanded to 59%, aided by a tariff refund, while SG&A fell sharply due to lower merger costs.
